189 related articles for article (PubMed ID: 32389634)
41. Modulating the Activity of the Human Organic Cation Transporter 2 Emerges as a Potential Strategy to Mitigate Unwanted Toxicities Associated with Cisplatin Chemotherapy.
Hucke A; Kantauskaite M; Köpp TN; Wehe CA; Karst U; Nedvetsky PI; Ciarimboli G
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474165
[TBL] [Abstract][Full Text] [Related]
42. Glutamine protects against cisplatin-induced nephrotoxicity by decreasing cisplatin accumulation.
Kim HJ; Park DJ; Kim JH; Jeong EY; Jung MH; Kim TH; Yang JI; Lee GW; Chung HJ; Chang SH
J Pharmacol Sci; 2015 Jan; 127(1):117-26. PubMed ID: 25704027
[TBL] [Abstract][Full Text] [Related]
43. The protective effects of Ribes diacanthum Pall on cisplatin-induced nephrotoxicity in mice.
Tilyek A; Chai C; Hou X; Zhou B; Zhang C; Cao Z; Yu B
J Ethnopharmacol; 2016 Feb; 178():297-306. PubMed ID: 26481606
[TBL] [Abstract][Full Text] [Related]
44. Organic Cation Transporter 1 and 3 Contribute to the High Accumulation of Dehydrocorydaline in the Heart.
Chen Y; Li C; Yi Y; Du W; Jiang H; Zeng S; Zhou H
Drug Metab Dispos; 2020 Oct; 48(10):1074-1083. PubMed ID: 32723846
[TBL] [Abstract][Full Text] [Related]
45. Inhibitory interaction of flavonoids with organic cation transporter 2 and their structure-activity relationships for predicting nephroprotective effects.
Tan H; Wang F; Hu J; Duan X; Bai W; Wang X; Wang B; Su Y; Hu J
J Appl Toxicol; 2023 Oct; 43(10):1421-1435. PubMed ID: 37057715
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine.
Sun S; Wang K; Lei H; Li L; Tu M; Zeng S; Zhou H; Jiang H
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():1-6. PubMed ID: 24246570
[TBL] [Abstract][Full Text] [Related]
47. Cisplatin-induced renal injury is independently mediated by OCT2 and p53.
Sprowl JA; Lancaster CS; Pabla N; Hermann E; Kosloske AM; Gibson AA; Li L; Zeeh D; Schlatter E; Janke LJ; Ciarimboli G; Sparreboom A
Clin Cancer Res; 2014 Aug; 20(15):4026-35. PubMed ID: 24916697
[TBL] [Abstract][Full Text] [Related]
48. MATE-1 modulation by kinin B1 receptor enhances cisplatin efflux from renal cells.
Estrela GR; Wasinski F; Felizardo RJF; Souza LL; Câmara NOS; Bader M; Araujo RC
Mol Cell Biochem; 2017 Apr; 428(1-2):101-108. PubMed ID: 28161805
[TBL] [Abstract][Full Text] [Related]
49. Effect of lycopene against cisplatin-induced acute renal injury in rats: organic anion and cation transporters evaluation.
Erman F; Tuzcu M; Orhan C; Sahin N; Sahin K
Biol Trace Elem Res; 2014 Apr; 158(1):90-5. PubMed ID: 24531880
[TBL] [Abstract][Full Text] [Related]
50. Role of Mouse Organic Cation Transporter 2 for Nephro- and Peripheral Neurotoxicity Induced by Chemotherapeutic Treatment with Cisplatin.
Hucke A; Schröter R; Ceresa C; Chiorazzi A; Canta A; Semperboni S; Marmiroli P; Cavaletti G; Gess B; Ciarimboli G
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511245
[TBL] [Abstract][Full Text] [Related]
51. Cadmium exposure enhances organic cation transporter 2 trafficking to the kidney membrane and exacerbates cisplatin nephrotoxicity.
Yang H; Tang J; Guo D; Zhao Q; Wen J; Zhang Y; Obianom ON; Zhou S; Zhang W; Shu Y
Kidney Int; 2020 Apr; 97(4):765-777. PubMed ID: 32061436
[TBL] [Abstract][Full Text] [Related]
52. Influence of Oct1/Oct2-deficiency on cisplatin-induced changes in urinary N-acetyl-beta-D-glucosaminidase.
Franke RM; Kosloske AM; Lancaster CS; Filipski KK; Hu C; Zolk O; Mathijssen RH; Sparreboom A
Clin Cancer Res; 2010 Aug; 16(16):4198-206. PubMed ID: 20601443
[TBL] [Abstract][Full Text] [Related]
53. [Clinical and Fundamental Approach for Chemotherapy-induced Adverse Effect Attenuation by Oncology Pharmacy Specialists].
Saito Y
Yakugaku Zasshi; 2020; 140(12):1415-1419. PubMed ID: 33268682
[TBL] [Abstract][Full Text] [Related]
54. Multiple Drug Transporters Are Involved in Renal Secretion of Entecavir.
Yang X; Ma Z; Zhou S; Weng Y; Lei H; Zeng S; Li L; Jiang H
Antimicrob Agents Chemother; 2016 Oct; 60(10):6260-70. PubMed ID: 27503646
[TBL] [Abstract][Full Text] [Related]
55. Dual function of OCT2 and MATE1 in cisplatin induced nephrotoxicity.
El-Arabey AA
Pharmacol Res; 2017 May; 119():493. PubMed ID: 27890551
[No Abstract] [Full Text] [Related]
56. Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients.
Ciarimboli G; Lancaster CS; Schlatter E; Franke RM; Sprowl JA; Pavenstädt H; Massmann V; Guckel D; Mathijssen RH; Yang W; Pui CH; Relling MV; Herrmann E; Sparreboom A
Clin Cancer Res; 2012 Feb; 18(4):1101-8. PubMed ID: 22223530
[TBL] [Abstract][Full Text] [Related]
57. Wnt/β-catenin agonist BIO alleviates cisplatin-induced nephrotoxicity without compromising its efficacy of anti-proliferation in ovarian cancer.
Sun Z; Xu S; Cai Q; Zhou W; Jiao X; Bao M; Yu X
Life Sci; 2020 Dec; 263():118672. PubMed ID: 33121990
[TBL] [Abstract][Full Text] [Related]
58. [Platinum agent-induced nephrotoxicity via organic cation transport system].
Yonezawa A
Yakugaku Zasshi; 2012; 132(11):1281-5. PubMed ID: 23123720
[TBL] [Abstract][Full Text] [Related]
59. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
60. Rapamycin Is Not Protective against Ischemic and Cisplatin-Induced Kidney Injury.
Andrianova NV; Zorova LD; Babenko VA; Pevzner IB; Popkov VA; Silachev DN; Plotnikov EY; Zorov DB
Biochemistry (Mosc); 2019 Dec; 84(12):1502-1512. PubMed ID: 31870254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
